March 24, 2017

Patients with drug-resistant tuberculosis (MDR-TB) have to take a fistful of pills and injections daily for up to two years. Side effects of these toxic drugs can include permanent deafness, nausea and vomiting, blindness, and psychosis. After decades without any new TB drugs, two powerful, less toxic medicines were finally released five years ago. But most patients can't get access to them. This needs to change.

March 21, 2017

Winile is a multidrug-resistant tuberculosis (MDR-TB) patient with Doctors Without Borders/Médecins Sans Frontières (MSF) in Swaziland, and one of the many who have lost their hearing due to the toxicity of available MDR-TB drugs. Through an MSF program in Swaziland, she has learned sign language so she can continue to communicate.

March 23, 2015

MDR-TB is deadly and a major public health issue, but for the past 50 years it has largely been ignored. Now, the needs of patients suffering from tuberculosis are finally being addressed.

April 15, 2014

Every year sees 60,000 more Cambodians infected with tuberculosis. The high prevalence of TB in Cambodia is pushing MSF to innovate.

March 17, 2014

For patients in Armenia who did not respond to the treatment available for multidrug-resistant tuberculosis (MDR-TB) there were simply no more treatment options before 2013.

March 17, 2014

Marta is receiving bedaquilin and impenem for her extensively drug-resistant tuberculosis (XDR-TB) in Yerevan, Armenia. These are not new drugs but they are newly available in Armenia and can make treatment more effective. But, says TB doctor Hakob Atsheyan, "you can say this is a last chance."

Pages